SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| MEDADVISOR LIMITED | 30/11/2015 | |
| EXALT RESOURCES LIMITED | 30/11/2015 |
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)The suspension of trading in the securities of MedAdvisor Limited will be lifted from the commencement of trading on Friday, 10 October 2025 following lodgement of its annual financial report. | 09/10/2025 |
The company lodges its annual report for 2025. | 09/10/2025 |
The company will hold its annual general meeting at 10:00am (Sydney time) on 26 November 2025 as a virtual meeting. | 08/10/2025 |
The company's securities suspended for not submitting report. | 03/10/2025 |
The securities of the company will be suspended from quotation under Listing Rule 17.5 starting 1 October 2025, due to the failure to lodge the required periodic report by the deadline. If the report is submitted between the market announcements office's closure on 30 September 2025 and the suspension, the securities will typically be reinstated for trading the following day. | 01/10/2025 |
The suspension of trading in the securities of MedAdvisor Limitedwill be lifted immediatly following the release by MDR of an announcement regarding the outcome of a Court application under section 1322 of the Corporations Act 2001. | 02/05/2025 |
The company has received court orders to rectify an administrative oversight related to the late placement of a cleansing notice for fully paid ordinary shares. | 02/05/2025 |
The company releases its appendix 3G. | 01/05/2025 |
The company releases its 3Q FY25 Presentation. | 30/04/2025 |
The company releases its 4C and quarterly activity report. | 30/04/2025 |
The company will hold a 3Q FY25 investor webinar on 30 April 2025, featuring a presentation by CEO Rick Ratliff and CFO Ancila Desai. | 29/04/2025 |
The securities of MedAdvisor Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of MDR, pending the release of an announcement regarding a pending Court application under section 1322 of the Corporations Act 2001 deeming the cleansing notice lodged on the ASX Market Announcements Platform on 23 April 2025 to be effective from the date of issue of the shares the subject of the Cleansing Notice. | 29/04/2025 |
The suspension of trading in the securities of MedAdvisor Limited will be lifted immediately, following the release by MDR of an announcement regarding the outcome of the Placement and the institutional component of the Entitlement Offer. | 12/11/2020 |
MedAdvisor successfully completes placement and institutional entitlement offer with $35 million to acquire US-based Adheris Health. | 12/11/2020 |
The company requests that a further voluntary suspension of the company's securities from the commencement of trading on 10 November 2020 until the earliest of such time as the company makes an announcement in relation to the outcome of the institutional component of the offer; the opening of trading on 12 November 2020; and the company separately requests that the voluntary suspension be lifted. | 10/11/2020 |
The company requests a further voluntary suspension of its securities from the commencement of trading on 10 November 2020 until the earliest of: such time as the company makes an announcement to the market in relation to the outcome of the institutional component of the offer; the open of trading on 12 November 2020; and the company separately requests that the voluntary suspension be lifted. | 10/11/2020 |
The company releases a cleansing notice in respect of accelerated non-renounceable pro-rata entitlement offer. | 06/11/2020 |
The company releases an investor presentation update on the Adheris acquisition. | 06/11/2020 |
The company has adjusted the price for the capital raise as it forges ahead to acquire US-based Adheris Health. MedAdvisor has elected to price the deal at 38 cents which is expected to allow the company to attract a broader cohort of new strategic investors to the register. The maximum amount that MedAdvisor may raise under the placement is approximately AUD $23.5M. The maximum amount that MedAdvisor may raise under the entitlement offer is approximately AUD $37.7M. | 06/11/2020 |
The securities of MedAdvisor Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of MDR, pending the release of an announcement regarding an acquisition and a capital raising. | 06/11/2020 |
we understand that on or about this date the company consolidated its shares 1 for 7 | 28/11/2019 |
The securities of MedAdvisor Limited (formerly Exalt Resources Limited) (the "Company") will be reinstated to official quotation from the commencement of trading on Tuesday 1 December 2015, following the Company's compliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. 387,406,652 fully paid ordinary shares Security Code: MDR | 30/11/2015 |
name changed from Exalt Resources Limited | 30/11/2015 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 08/11/2023 | Jim Xenos | -6,846,955 | $0.180 | $1,232,452.00 |
| 17/11/2021 | Jim Xenos | -6,846,955 | $0.360 | $2,464,904.00 |
| 27/06/2017 | Peter Bennetto | 15,000 | $0.280 | $4,200.00 |
| 15/03/2017 | Jim Xenos | 300,000 | $0.032 | $9,630.00 |
| 15/03/2017 | Peter Bennetto | 200,000 | $0.032 | $6,400.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Rick Ratliff | Managing Director, CEO | 18/07/2022 |
| Ruba El-Afifi | COO | 10/08/2021 |
| Lucas Merrow | Non Exec Director | 10/08/2021 |
| Sean Slattery | Executive Director, CFO | 21/07/2025 |
| Kate Hill | Interim Chairman | 24/05/2023 |
| Gillian Nairn | Company Secretary | 11/12/2024 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
